Nov 04, 2024 / 09:30PM GMT
Operator
Good afternoon and welcome to Separate Pharmaceutical third quarter person 24 financial results conference call. At this time, all participants are in listen-only mode later, we will conduct a question answer session, instructions will follow at that time. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Boso of IC R Health care, investor relations. Representative of Separate you may begin.
Peter Vozzo - ICR Healthcare - Investor Relations
Thank you Marvin. Good afternoon, everyone. And thank you for joining us today for Supernus Pharmaceuticals third quarter, 2024 financial results conference call today. After the close of the market, the company issued a press release announcing these results on the call with me. Today are Sna's Chief Executive Officer, Jack Guitar and Chief Financial Officer Tim Deck.
Today's call is being made available via the investor relations section of the company's website at Ir dot superna dotcom. During the course of this call management may make certain forward
Q3 2024 Supernus Pharmaceuticals Inc Earnings Call Transcript
Nov 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers